Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms. uri icon

Overview

publication date

  • October 21, 2021

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Bridged Bicyclo Compounds, Heterocyclic
  • Myeloproliferative Disorders
  • Sulfonamides

Identity

Scopus Document Identifier

  • 85118226517

Digital Object Identifier (DOI)

  • 10.1002/ajh.26381

PubMed ID

  • 34674293